To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
SurvivorNet Jay Yang, M.D. , hematologist, medical oncologist and leader of the Hematology Oncology Multidisciplinary Team at Karmanos, talks about the available treatments for patients with chronic myeloid leukemia (CML) and the possible side effects. Read the article here .
SurvivorNet Chronic myeloid leukemia (CML) is a cancer of the white blood cells. Jay Yang, M.D. , hematologist, medical oncologist and leader of the Hematology Oncology Multidisciplinary Team at Karmanos, comments on diagnosis of CML, treatment options and what doctors now know about treating patients who have achieved a deep remission. Read the article here .
OncLive Jay Yang, M.D. , leader of the Hematology Oncology Multidisciplinary Team at Karmanos Cancer Institute explains that most mantle cell lymphoma (MCL) patients will need treatment although there is not a true standard of care for the disease. Read the full article here.